Psilocybin-containing tea bag offers substitute for whole mushrooms and other solid therapeutics VANCOUVER, B.C, Oct. 5, 2022 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that its research division, Numinus Bioscience…


Previous articleMindset Pharma Selects Lead Clinical Candidates From “Family 2” of its Next Generation Psychedelic Drug Portfolio
Next articleSilo Pharma to Present at the Dawson James Small Cap Growth Conference on October 12